Follow Us:
Thursday, March 04, 2021

India pharma sector


US Pharma giant to set up global R&D headquarters in Ahmedabad

December 23, 2020 7:01 pm

Currently, Baxter has a research and development and information technology centre in Bengaluru and a manufacturing unit in Ahmedabad, where the company is manufacturing generic injectables.

HealthMin plans crowdfunding platform to help treat rare diseases

January 14, 2020 3:47 am

The draft National Policy for Rare Diseases proposes a digital platform for bringing together notified hospitals with such patients and prospective donors.

Day after key diabetes drug goes off patent, 20 generics send prices down by up to 70%

December 11, 2019 4:36 am

Vildagliptin, which belongs to DPP-4 class of drugs, was launched in India in 2008 for treating type-2 diabetes.

Wockhardt taken to NCLT over unpaid dues worth Rs 1.55 crore

October 22, 2019 3:31 am

Wockhardt’s payables have been on the rise over the last three years, with the company reporting over Rs 800 crore in trade payables at the end of March 31, 2019.

Drug regulator flags Piramal’s Supradyn, KAPL’s painkiller as ‘not of standard quality’

August 15, 2019 4:36 am

Central Drugs Standard Control Organisation this month labelled these batches as “not of standard quality” for failing tests conducted in July.

US FDA finds quality, data issues at Dadra plant of Sun Pharma

April 25, 2019 2:42 am

Sun Pharma got Form 483 which is issued when investigators observe conditions they deem to be violations of US drug regulations.

‘Despite ban, motion sickness medicine buclizine being sold as appetite stimulant’

March 29, 2019 3:19 am

The findings have caused a public health activist to urge the Delhi High Court to direct the government to initiate “criminal” proceedings against the medicine’s manufacturer — Mankind Pharmaceuticals Ltd.

Drugs and medical devices: ‘Price cap helped patients save around Rs 15,000 crore’

November 21, 2018 6:35 am

According to the estimates of the National Pharmaceutical Pricing Authority (NPPA), patients across the country have saved around Rs 15,000 crore under the government’s initiative of ensuring affordable, quality medicines for all, Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya said in a statement.

Maharashtra Druggists’ body to pharma firms: ‘Refrain from unethical practices to boost sales’

August 30, 2018 1:37 am

The letter dated August 27, states that “we have come to know from reliable market sources that your company’s MR/manager comes in the month-end to complete primary target” and then this employee is “adjusting” by paying from his incentives/salary, which is “highly objectionable and warrant your immediate attention”.

Oxytocin: Drug regulator calls for ‘strict vigil’

August 07, 2018 1:21 am

CDSCO has also requested state drug regulators to sensitise its inspectorate staff “to keep strict vigil on manufacture, sale and distribution of Oxytocin in the country”.